Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. Its lead product candidate includes APPY1, a blood-based diagnostic test designed to aid in the evaluation of patients for acute appendicitis. The company, through its license agreement with Washington University in St. Louis, develops, markets, distributes, imports, and exports luteinizing hormone and/or follicle-stimulating hormone products for cattle, equine, and swine animals. For more information, visit the company’s website at www.venaxis.com.